business

ROVI cuts 2026 revenue guidance on lower pharma demand

Investing.com · May 6, 2026, 7:24 AM · Also reported by 1 other source

Read full story on Investing.com → More top stories

Also covered by

CNBC Super Micro stock jumps 19% on guidance beat as revenue more than doubles

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

ROVI cuts 2026 revenue guidance on lower pharma demand

Also covered by

More in business